Guardant Health
242 hedge funds and large institutions have $4.72B invested in Guardant Health in 2019 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 92 increasing their positions, 62 reducing their positions, and 36 closing their positions.
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
69% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 36
48% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 62
12% more funds holding
Funds holding: 217 → 242 (+25)
3.57% less ownership
Funds ownership: 83.02% → 79.45% (-3.6%)
28% less capital invested
Capital invested by funds: $6.57B → $4.72B (-$1.85B)
31% less call options, than puts
Call options by funds: $43.2M | Put options by funds: $62.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$253M |
| 2 |
JP Morgan Chase
New York
|
+$166M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$66.9M |
| 4 |
Jennison Associates
New York
|
+$54.8M |
| 5 |
Morgan Stanley
New York
|
+$53.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$432M |
| 2 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$411M |
| 3 |
VS
VK Services
Menlo Park,
California
|
-$220M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$65.8M |
| 5 |
Coatue Management
New York
|
-$35.5M |
GH Hedge Fund Activity: Q3 2019 in Review
242 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2019, worth a combined $4.72B — down 28% from $6.57B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new GH positions and 36 closed out — a net gain of 25 holders — while 92 added to existing stakes and 62 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $253M. The largest seller was SB Investment Advisers (UK), cutting an estimated $432M.
- 242 institutional investors held Guardant Health (GH) as of Q3 2019, up from 217 in Q2 2019.
- Funds reported $4.72B of Guardant Health stock for Q3 2019, down 28% quarter-over-quarter.
- 61 funds opened new Guardant Health positions in Q3 2019 and 36 closed out, a net change of +25 holders.
- The largest Guardant Health buyer in Q3 2019 was Viking Global Investors, an estimated $253M added.
- The largest Guardant Health seller in Q3 2019 was SB Investment Advisers (UK), an estimated $432M sold.
Based on aggregated 13F filings for Q3 2019.